相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Do We Have Good Activity Indices in Systemic Sclerosis?
Laura Groseanu et al.
CURRENT RHEUMATOLOGY REVIEWS (2022)
Development and validation of a patient-reported outcome measure for systemic sclerosis: the EULAR Systemic Sclerosis Impact of Disease (ScleroID) questionnaire
Mike O. Becker et al.
ANNALS OF THE RHEUMATIC DISEASES (2022)
Expansion of Fc gamma Receptor IIIa-Positive Macrophages, Ficolin 1-Positive Monocyte-Derived Dendritic Cells, and Plasmacytoid Dendritic Cells Associated With Severe Skin Disease in Systemic Sclerosis
Dan Xue et al.
ARTHRITIS & RHEUMATOLOGY (2022)
Rituximab versus tocilizumab in anti-TNF inadequate responder patients with rheumatoid arthritis (R4RA): 16-week outcomes of a stratified, biopsy-driven, multicentre, open-label, phase 4 randomised controlled trial
Frances Humby et al.
LANCET (2021)
Safety and Efficacy of B-Cell Depletion with Rituximab for the Treatment of Systemic Sclerosis-associated Pulmonary Arterial Hypertension A Multicenter, Double-Blind, Randomized, Placebo-controlled Trial
Roham T. Zamanian et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2021)
A Phase-2 NIH-sponsored Randomized Clinical Trial of Rituximab in Scleroderma-associated Pulmonary Arterial Hypertension Did Not Reach Significance for Its Endpoints End of Story? Not So Fast!
Yongneng Zhang et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2021)
Clinical Relevance of the Serial Measurement of Krebs von den Lungen-6 Levels in Patients with Systemic Sclerosis-Associated Interstitial Lung Disease
Yuichiro Shirai et al.
DIAGNOSTICS (2021)
Efficacy and safety of voclosporin versus placebo for lupus nephritis (AURORA 1): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial
Brad H. Rovin et al.
LANCET (2021)
All-cause mortality in systemic rheumatic diseases under treatment compared with the general population, 2015-2019
Vasiliki-Kalliopi Bournia et al.
RMD OPEN (2021)
Disparate Interferon Signaling and Shared Aberrant Basaloid Cells in Single-Cell Profiling of Idiopathic Pulmonary Fibrosis and Systemic Sclerosis-Associated Interstitial Lung Disease
Eleanor Valenzi et al.
FRONTIERS IN IMMUNOLOGY (2021)
Calcinosis in systemic sclerosis
Mohammad Ryadh Pokeerbux et al.
JOINT BONE SPINE (2021)
Outcome measurement instrument selection for lung physiology in systemic sclerosis associated interstitial lung disease: A systematic review using the OMERACT filter 2.1 process
David Roofeh et al.
SEMINARS IN ARTHRITIS AND RHEUMATISM (2021)
Myofibroblast transcriptome indicates SFRP2hi fibroblast progenitors in systemic sclerosis skin
Tracy Tabib et al.
NATURE COMMUNICATIONS (2021)
Serum IGFBP-2 in systemic sclerosis as a prognostic factor of lung dysfunction
Julien Guiot et al.
SCIENTIFIC REPORTS (2021)
An update on targeted therapies in systemic sclerosis based on a systematic review from the last 3 years
Corrado Campochiaro et al.
ARTHRITIS RESEARCH & THERAPY (2021)
Performance of the UCLA Scleroderma Clinical Trials Consortium Gastrointestinal Tract 2.0 instrument as a clinical decision aid in the routine clinical care of patients with systemic sclerosis
Norina Zampatti et al.
ARTHRITIS RESEARCH & THERAPY (2021)
18F-FDG positron emission tomography scanning in systemic sclerosis-associated interstitial lung disease: a pilot study
Emmanuel Ledoult et al.
ARTHRITIS RESEARCH & THERAPY (2021)
Considerations for a combined index for limited cutaneous systemic sclerosis to support drug development and improve outcomes
Alain Lescoat et al.
JOURNAL OF SCLERODERMA AND RELATED DISORDERS (2021)
Ultrasound in the Assessment of Interstitial Lung Disease in Systemic Sclerosis: A Systematic Literature Review by the OMERACT Ultrasound Group
Marwin Gutierrez et al.
JOURNAL OF RHEUMATOLOGY (2020)
Scope and Consistency of Outcomes Reported in Trials of Patients With Systemic Sclerosis
Daniel Sumpton et al.
ARTHRITIS CARE & RESEARCH (2020)
Abatacept in Early Diffuse Cutaneous Systemic Sclerosis: Results of a Phase II Investigator-Initiated, Multicenter, Double-Blind, Randomized, Placebo-Controlled Trial
Dinesh Khanna et al.
ARTHRITIS & RHEUMATOLOGY (2020)
Performance of ultra-high-frequency ultrasound in the evaluation of skin involvement in systemic sclerosis: a preliminary report
Esperanza Naredo et al.
RHEUMATOLOGY (2020)
Musculoskeletal hand involvement in systemic sclerosis
Robert David Sandler et al.
SEMINARS IN ARTHRITIS AND RHEUMATISM (2020)
Etiology, Risk Factors, and Biomarkers in Systemic Sclerosis with Interstitial Lung Disease
Dinesh Khanna et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2020)
Predictors of progression in systemic sclerosis patients with interstitial lung disease
Oliver Distler et al.
EUROPEAN RESPIRATORY JOURNAL (2020)
Performance of the 2017 EUSTAR activity index in an scleroderma cohort
Laura Ross et al.
CLINICAL RHEUMATOLOGY (2020)
Detection, screening, and classification of interstitial lung disease in patients with systemic sclerosis
Anna-Maria Hoffmann-Vold et al.
CURRENT OPINION IN RHEUMATOLOGY (2020)
Two-Year, Randomized, Controlled Trial of Belimumab in Lupus Nephritis
Richard Furie et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Tocilizumab in systemic sclerosis: a randomised, double-blind, placebo-controlled, phase 3 trial
Dinesh Khanna et al.
LANCET RESPIRATORY MEDICINE (2020)
Enrichment Strategy for Systemic Sclerosis Clinical Trials Targeting Skin Fibrosis: A Prospective, Multiethnic Cohort Study
Carina Mihai et al.
ACR OPEN RHEUMATOLOGY (2020)
Biomarkers as an opportunity to stratify for outcome in systemic sclerosis
Giuseppina Abignano et al.
EUROPEAN JOURNAL OF RHEUMATOLOGY (2020)
Effects of N-acetylcysteine on Pulmonary Functions in Patients with Systemic Sclerosis: A Randomized Double Blind, Placebo Controlled Study
Samrad Mehrabi et al.
CURRENT RHEUMATOLOGY REVIEWS (2020)
The identification and management of interstitial lung disease in systemic sclerosis: evidence-based European consensus statements
Anna-Maria Hoffmann-Vold et al.
LANCET RHEUMATOLOGY (2020)
The clinical value of the delta finger to palm distance in systemic sclerosis
A. Javinani et al.
REUMATISMO (2020)
Patient-reported outcome measures in systemic sclerosis-related interstitial lung disease for clinical practice and clinical trials
Lesley Ann Saketkoo et al.
JOURNAL OF SCLERODERMA AND RELATED DISORDERS (2020)
High-throughput quantitative histology in systemic sclerosis skin disease using computer vision
Chase Correia et al.
ARTHRITIS RESEARCH & THERAPY (2020)
Psychometric validation of the Hand Disability in Systemic Sclerosis-Digital Ulcers (HDISS-DU®) patient-reported outcome instrument
Luc Mouthon et al.
ARTHRITIS RESEARCH & THERAPY (2020)
Ultrasonography for the Assessment of Skin in Systemic Sclerosis: A Systematic Review
Tania Santiago et al.
ARTHRITIS CARE & RESEARCH (2019)
Nintedanib for Systemic Sclerosis-Associated Interstitial Lung Disease
Oliver Distler et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
A double-blind randomized placebo-controlled trial of probiotics in systemic sclerosis associated gastrointestinal disease
Andrea Hsiu Ling Low et al.
SEMINARS IN ARTHRITIS AND RHEUMATISM (2019)
CXCL4 assembles DNA into liquid crystalline complexes to amplify TLR9-mediated interferon-α production in systemic sclerosis
Roberto Lande et al.
NATURE COMMUNICATIONS (2019)
Single-Cell RNA-Seq Technologies and Related Computational Data Analysis
Geng Chen et al.
FRONTIERS IN GENETICS (2019)
Tracking Impact of Interstitial Lung Disease in Systemic Sclerosis in a Complete Nationwide Cohort
Anna-Maria Hoffmann-Vold et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2019)
Proliferating SPP1/MERTK-expressing macrophages in idiopathic pulmonary fibrosis
Christina Morse et al.
EUROPEAN RESPIRATORY JOURNAL (2019)
Progression of Interstitial Lung Disease in Systemic Sclerosis: The Importance of Pneumoproteins Krebs von den Lungen 6 and CCL18
Elizabeth R. Volkmann et al.
ARTHRITIS & RHEUMATOLOGY (2019)
Revised European Scleroderma Trials and Research Group Activity Index is the best predictor of short-term severity accrual
Serena Fasano et al.
ANNALS OF THE RHEUMATIC DISEASES (2019)
Vasodilators and low-dose acetylsalicylic acid are associated with a lower incidence of distinct primary myocardial disease manifestations in systemic sclerosis: results of the DeSScipher inception cohort study
Gabriele Valentini et al.
ANNALS OF THE RHEUMATIC DISEASES (2019)
Single-cell analysis reveals fibroblast heterogeneity and myofibroblasts in systemic sclerosis-associated interstitial lung disease
Eleanor Valenzi et al.
ANNALS OF THE RHEUMATIC DISEASES (2019)
Myeloablation followed by autologous stem cell transplantation normalises systemic sclerosis molecular signatures
Shervin Assassi et al.
ANNALS OF THE RHEUMATIC DISEASES (2019)
Calcinosis in scleroderma made crystal clear
Vivien Hsu et al.
CURRENT OPINION IN RHEUMATOLOGY (2019)
Prognostic value of cardiopulmonary exercise testing in patients with systemic sclerosis
Ralf Ewert et al.
BMC PULMONARY MEDICINE (2019)
Visualisation of interstitial lung disease by molecular imaging of integrin αvβ3 and somatostatin receptor 2
Janine Schniering et al.
ANNALS OF THE RHEUMATIC DISEASES (2019)
Performance of Candidate Serum Biomarkers for Systemic Sclerosis-Associated Interstitial Lung Disease
Muriel Elhai et al.
ARTHRITIS & RHEUMATOLOGY (2019)
Challenges in systemic sclerosis trial design
Christopher P. Denton
SEMINARS IN ARTHRITIS AND RHEUMATISM (2019)
Skin thickness score as a surrogate marker of organ involvements in systemic sclerosis: a retrospective observational study
Kazuki M. Matsuda et al.
ARTHRITIS RESEARCH & THERAPY (2019)
Synovial Tissue Heterogeneity in Rheumatoid Arthritis and Changes With Biologic and Targeted Synthetic Therapies to Inform Stratified Therapy
Lylia Ouboussad et al.
FRONTIERS IN MEDICINE (2019)
Reliability and Minimal Clinically Important Differences of FVC Results from the Scleroderma Lung Studies (SLS-I and SLS-II)
Suzanne Kafaja et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2018)
SFRP2/DPP4 and FMO1/LSP1 Define Major Fibroblast Populations in Human Skin
Tracy Tabib et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2018)
Spatial and Single-Cell Transcriptional Profiling Identifies Functionally Distinct Human Dermal Fibroblast Subpopulations
Christina Philippeos et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2018)
Skin Gene Expression Is Prognostic for the Trajectory of Skin Disease in Patients With Diffuse Cutaneous Systemic Sclerosis
Giuseppina Stifano et al.
ARTHRITIS & RHEUMATOLOGY (2018)
Role of C-Reactive Protein at Sites of Inflammation and Infection
Nicola R. Sproston et al.
FRONTIERS IN IMMUNOLOGY (2018)
Prediction of therapeutic response before and during i.v. cyclophosphamide pulse therapy for interstitial lung disease in systemic sclerosis: A longitudinal observational study
Hayakazu Sumida et al.
JOURNAL OF DERMATOLOGY (2018)
Safety and efficacy of subcutaneous tocilizumab in systemic sclerosis: results from the open-label period of a phase II randomised controlled trial (faSScinate)
Dinesh Khanna et al.
ANNALS OF THE RHEUMATIC DISEASES (2018)
pDCs in lung and skin fibrosis in a bleomycin-induced model and patients with systemic sclerosis
Suzanne Kafaja et al.
JCI INSIGHT (2018)
Evaluation of 99mTc-rhAnnexin V-128 SPECT/CT as a diagnostic tool for early stages of interstitial lung disease associated with systemic sclerosis
Janine Schniering et al.
ARTHRITIS RESEARCH & THERAPY (2018)
Pulmonary function tests as outcomes for systemic sclerosis interstitial lung disease
Melissa Caron et al.
EUROPEAN RESPIRATORY REVIEW (2018)
The European Scleroderma Trials and Research group (EUSTAR) task force for the development of revised activity criteria for systemic sclerosis: derivation and validation of a preliminarily revised EUSTAR activity index
Gabriele Valentini et al.
ANNALS OF THE RHEUMATIC DISEASES (2017)
Update of EULAR recommendations for the treatment of systemic sclerosis
Otylia Kowal-Bielecka et al.
ANNALS OF THE RHEUMATIC DISEASES (2017)
Predictive value of European Scleroderma Group Activity Index in an early scleroderma cohort
Tatiana Nevskaya et al.
RHEUMATOLOGY (2017)
Points to consider for designing trials in systemic sclerosis patients with arthritic involvement
Philip Clements et al.
RHEUMATOLOGY (2017)
Assessment of skin involvement in systemic sclerosis
Gabor Kumanovics et al.
RHEUMATOLOGY (2017)
CCL2 in the Circulation Predicts Long-Term Progression of Interstitial Lung Disease in Patients With Early Systemic Sclerosis Data From Two Independent Cohorts
Minghua Wu et al.
ARTHRITIS & RHEUMATOLOGY (2017)
Short-Term Pulmonary Function Trends Are Predictive of Mortality in Interstitial Lung Disease Associated With Systemic Sclerosis
Nicole S. Goh et al.
ARTHRITIS & RHEUMATOLOGY (2017)
Serum KL-6 and surfactant protein-D as monitoring and predictive markers of interstitial lung disease in patients with systemic sclerosis and mixed connective tissue disease
Hideaki Yamakawa et al.
JOURNAL OF THORACIC DISEASE (2017)
Disease activity, handgrip strengths, and hand dexterity in patients with rheumatoid arthritis
D. Palamar et al.
CLINICAL RHEUMATOLOGY (2017)
Standardization of the modified Rodnan skin score for use in clinical trials of systemic sclerosis
Dinesh Khanna et al.
JOURNAL OF SCLERODERMA AND RELATED DISORDERS (2017)
Development and validation of a patient-reported outcome instrument for skin involvement in patients with systemic sclerosis
Ada Man et al.
ANNALS OF THE RHEUMATIC DISEASES (2017)
Subclinical dermal involvement is detectable by high frequency ultrasound even in patients with limited cutaneous systemic sclerosis
A. Sulli et al.
ARTHRITIS RESEARCH & THERAPY (2017)
A prospective study of the 6 min walk test as a surrogate marker for haemodynamics in two independent cohorts of treatment-naive systemic sclerosis-associated pulmonary arterial hypertension
Sebastien Sanges et al.
ANNALS OF THE RHEUMATIC DISEASES (2016)
Prediction of improvement in skin fibrosis in diffuse cutaneous systemic sclerosis: a EUSTAR analysis
Rucsandra Dobrota et al.
ANNALS OF THE RHEUMATIC DISEASES (2016)
High Level of Chemokine CCL18 Is Associated With Pulmonary Function Deterioration, Lung Fibrosis Progression, and Reduced Survival in Systemic Sclerosis
Anna-Maria Hoffmann-Vold et al.
CHEST (2016)
Interstitial lung disease in systemic sclerosis: progress in screening and early diagnosis
Oyvind Molberg et al.
CURRENT OPINION IN RHEUMATOLOGY (2016)
FDG-PET/CT in the prediction of pulmonary function improvement in nonspecific interstitial pneumonia. A Pilot Study
V. Jacquelin et al.
EUROPEAN JOURNAL OF RADIOLOGY (2016)
Elevated Serum Krebs von den Lungen-6 in Early Disease Predicts Subsequent Deterioration of Pulmonary Function in Patients with Systemic Sclerosis and Interstitial Lung Disease
Masataka Kuwana et al.
JOURNAL OF RHEUMATOLOGY (2016)
Safety and efficacy of subcutaneous tocilizumab in adults with systemic sclerosis (faSScinate): a phase 2, randomised, controlled trial
Dinesh Khanna et al.
LANCET (2016)
The relationship between skin symptoms and the scleroderma modification of the health assessment questionnaire, the modified Rodnan skin score, and skin pathology in patients with systemic sclerosis
Jessica Ziemek et al.
RHEUMATOLOGY (2016)
Validity and responsiveness of the Michigan Hand Questionnaire in patients with systemic sclerosis
Anne A. Schouffoer et al.
RHEUMATOLOGY (2016)
Using Optimal Test Assembly Methods for Shortening Patient-Reported Outcome Measures: Development and Validation of the Cochin Hand Function Scale-6: A Scleroderma Patient-Centered Intervention Network Cohort Study
Alexander W. Levis et al.
ARTHRITIS CARE & RESEARCH (2016)
Clinical Trial Design Issues in Systemic Sclerosis: an Update
Jessica K. Gordon et al.
CURRENT RHEUMATOLOGY REPORTS (2016)
Mycophenolate mofetil versus oral cyclophosphamide in scleroderma-related interstitial lung disease (SLS II): a randomised controlled, double-blind, parallel group trial
Donald P. Tashkin et al.
LANCET RESPIRATORY MEDICINE (2016)
Relationship between quantitative radiographic assessments of interstitial lung disease and physiological and clinical features of systemic sclerosis
Donald P. Tashkin et al.
ANNALS OF THE RHEUMATIC DISEASES (2016)
Changes in plasma CXCL4 levels are associated with improvements in lung function in patients receiving immunosuppressive therapy for systemic sclerosis-related interstitial lung disease
Elizabeth R. Volkmann et al.
ARTHRITIS RESEARCH & THERAPY (2016)
Fresolimumab treatment decreases biomarkers and improves clinical symptoms in systemic sclerosis patients
Lisa M. Rice et al.
JOURNAL OF CLINICAL INVESTIGATION (2015)
Connective Tissue Disease-associated Interstitial Lung Diseases (CTD-ILD) - Report from OMERACT CTD-ILD Working Group
Dinesh Khanna et al.
JOURNAL OF RHEUMATOLOGY (2015)
Reliability, validity and responsiveness to change of the Saint George's Respiratory Questionnaire in early diffuse cutaneous systemic sclerosis
Beth Wallace et al.
RHEUMATOLOGY (2015)
Ultrasound signs of pulmonary fibrosis in systemic sclerosis as timely indicators for chest computed tomography
M. Sperandeo et al.
SCANDINAVIAN JOURNAL OF RHEUMATOLOGY (2015)
Validation of a Novel Radiographic Scoring System for Calcinosis Affecting the Hands of Patients With Systemic Sclerosis
Lorinda Chung et al.
ARTHRITIS CARE & RESEARCH (2015)
Pulmonary Function Tests: High Rate of False-Negative Results in the Early Detection and Screening of Scleroderma-Related Interstitial Lung Disease
Yossra A. Suliman et al.
ARTHRITIS & RHEUMATOLOGY (2015)
A Longitudinal Biomarker for the Extent of Skin Disease in Patients With Diffuse Cutaneous Systemic Sclerosis
Lisa M. Rice et al.
ARTHRITIS & RHEUMATOLOGY (2015)
Patient Perspectives in OMERACT Provide an Anchor for Future Metric Development and Improved Approaches to Healthcare Delivery in Connective Tissue Disease Related Interstitial Lung Disease (CTD-ILD)
Shikha Mittoo et al.
CURRENT RESPIRATORY MEDICINE REVIEWS (2015)
The enhanced liver fibrosis test: a clinical grade, validated serum test, biomarker of overall fibrosis in systemic sclerosis
Giuseppina Abignano et al.
ANNALS OF THE RHEUMATIC DISEASES (2014)
Predictors of Mortality and Progression in Scleroderma-Associated Interstitial Lung Disease A Systematic Review
Tiffany A. Winstone et al.
CHEST (2014)
Scleroderma: the role of serum autoantibodies in defining specific clinical phenotypes and organ system involvement
Robyn T. Domsic
CURRENT OPINION IN RHEUMATOLOGY (2014)
Serum CCL18 is predictive for lung disease progression and mortality in systemic sclerosis
Jonas Schupp et al.
EUROPEAN RESPIRATORY JOURNAL (2014)
Autologous Hematopoietic Stem Cell Transplantation vs Intravenous Pulse Cyclophosphamide in Diffuse Cutaneous Systemic Sclerosis A Randomized Clinical Trial
Jacob M. van Laar et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2014)
Development of a Modified Hand Mobility in Scleroderma (HAMIS) Test and its Potential as an Outcome Measure in Systemic Sclerosis
Gunnel Sandqvist et al.
JOURNAL OF RHEUMATOLOGY (2014)
Reconciling Healthcare Professional and Patient Perspectives in the Development of Disease Activity and Response Criteria in Connective Tissue Disease-related Interstitial Lung Diseases
Lesley Ann Saketkoo et al.
JOURNAL OF RHEUMATOLOGY (2014)
Proteome-wide Analysis and CXCL4 as a Biomarker in Systemic Sclerosis
L. van Bon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
The Pro-Inflammatory Cytokine, Interleukin-6, Enhances the Polarization of Alternatively Activated Macrophages
Maria Ruweka Fernando et al.
PLOS ONE (2014)
Correlation of interferon-inducible chemokine plasma levels with disease severity in systemic sclerosis
Xiaochun Liu et al.
ARTHRITIS AND RHEUMATISM (2013)
Serum Interleukin 6 Is Predictive of Early Functional Decline and Mortality in Interstitial Lung Disease Associated with Systemic Sclerosis
Angelo De Lauretis et al.
JOURNAL OF RHEUMATOLOGY (2013)
Macitentan and Morbidity and Mortality in Pulmonary Arterial Hypertension
Tomas Pulido et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Tendon friction rubs in systemic sclerosis: a possible explanation-an ultrasound and magnetic resonance imaging study
Maria S. Stoenoiu et al.
RHEUMATOLOGY (2013)
Does C-Reactive Protein Predict the Long-Term Progression of Interstitial Lung Disease and Survival in Patients With Early Systemic Sclerosis?
Xiaochun Liu et al.
ARTHRITIS CARE & RESEARCH (2013)
Patterns and predictors of change in outcome measures in clinical trials in scleroderma: An individual patient meta-analysis of 629 subjects with diffuse cutaneous systemic sclerosis
P. A. Merkel et al.
ARTHRITIS AND RHEUMATISM (2012)
Intrinsic Gene Expression Subsets of Diffuse Cutaneous Systemic Sclerosis Are Stable in Serial Skin Biopsies
Sarah A. Pendergrass et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2012)
Ultrasound in the Assessment of Pulmonary Fibrosis in Connective Tissue Disorders: Correlation with High-Resolution Computed Tomography
Marika Tardella et al.
JOURNAL OF RHEUMATOLOGY (2012)
Treatment of Systemic Sclerosis-Associated Calcinosis: A Case Report of Rituximab-Induced Regression of CREST-Related Calcinosis and Review of the Literature
Dimitrios Daoussis et al.
SEMINARS IN ARTHRITIS AND RHEUMATISM (2012)
Serum CC chemokine ligand-18 predicts lung disease worsening in systemic sclerosis
K. P. Tiev et al.
EUROPEAN RESPIRATORY JOURNAL (2011)
Elevated MMP-7 levels in patients with systemic sclerosis: correlation with pulmonary involvement
Pia Moinzadeh et al.
EXPERIMENTAL DERMATOLOGY (2011)
Calcinosis cutis Part II. Treatment options
Nadine Reiter et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2011)
Autologous non-myeloablative haemopoietic stem-cell transplantation compared with pulse cyclophosphamide once per month for systemic sclerosis (ASSIST): an open-label, randomised phase 2 trial
Richard K. Burt et al.
LANCET (2011)
Utility of a simplified ultrasound assessment to assess interstitial pulmonary fibrosis in connective tissue disorders - preliminary results
Marwin Gutierrez et al.
ARTHRITIS RESEARCH & THERAPY (2011)
A Four-Gene Biomarker Predicts Skin Disease in Patients With Diffuse Cutaneous Systemic Sclerosis
G. Farina et al.
ARTHRITIS AND RHEUMATISM (2010)
Association of a KCNA5 Gene Polymorphism With Systemic Sclerosis-Associated Pulmonary Arterial Hypertension in the European Caucasian Population
J. Wipff et al.
ARTHRITIS AND RHEUMATISM (2010)
Osteopontin in the development of systemic sclerosis-relation to disease activity and organ manifestation
Johan M. Lorenzen et al.
RHEUMATOLOGY (2010)
Systemic Sclerosis-Associated Interstitial Lung Disease: Lessons from Clinical Trials, Outcome Measures, and Future Study Design
Dinesh Khanna et al.
CURRENT RHEUMATOLOGY REVIEWS (2010)
Reliability and Validity of the University of California, Los Angeles Scleroderma Clinical Trial Consortium Gastrointestinal Tract Instrument
Dinesh Khanna et al.
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH (2009)
Lack of Specificity of the 6-Minute Walk Test as an Outcome Measure for Patients with Systemic Sclerosis
Yoland Schoindre et al.
JOURNAL OF RHEUMATOLOGY (2009)
Measures of Response in Clinical Trials of Systemic Sclerosis: The Combined Response Index for Systemic Sclerosis (CRISS) and Outcome Measures in Pulmonary Arterial Hypertension Related to Systemic Sclerosis (EPOSS)
Dinesh Khanna et al.
JOURNAL OF RHEUMATOLOGY (2009)
Mechanisms of Disease: Scleroderma.
Armando Gabrielli et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Validity, reliability, and feasibility of durometer measurements of scleroderma skin disease in a multicenter treatment trial
Peter A. Merkel et al.
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH (2008)
Changes in causes of death in systemic sclerosis, 1972-2002
Virginia D. Steen et al.
ANNALS OF THE RHEUMATIC DISEASES (2007)
The natural course of progressive systemic sclerosis patients with interstitial lung involvement
Musellim Benan et al.
CLINICAL RHEUMATOLOGY (2007)
Assessing disability and quality of life in systemic sclerosis:: Construct validities of the Cochin Hand Function Scale, Health Assessment Questionnaire (HAQ), systemic sclerosis HAQ, and Medical Outcomes Study 36-Item Short Form Health Survey
Francois Rannou et al.
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH (2007)
Submaximal exercise testing in the assessment of interstitial lung disease secondary to systemic sclerosis: reproducibility and correlations of the 6-min walk test
M. H. Buch et al.
ANNALS OF THE RHEUMATIC DISEASES (2007)
Durometry for the assessment of skin disease in systemic sclerosis
Eugene Y. Kissin et al.
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH (2006)
Cyclophosphamide versus placebo in scleroderma lung disease
Donald P. Tashkin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Sildenafil citrate therapy for pulmonary arterial hypertension
N Galiè et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Elevated matrix metalloproteinase-9 in patients with systemic sclerosis
WU Kim et al.
ARTHRITIS RESEARCH & THERAPY (2005)
Immediate and long-term hemodynamic and clinical effects of Sildenafil in patients with pulmonary arterial hypertension receiving vasodilator therapy
S Bhatia et al.
MAYO CLINIC PROCEEDINGS (2003)
European Scleroderma Study Group to define disease activity criteria for systemic sclerosis. III. Assessment of the construct validity of the preliminary activity criteria
G Valentini et al.
ANNALS OF THE RHEUMATIC DISEASES (2003)
Composite outcomes in randomized trials - Greater precision but with greater uncertainty?
N Freemantle et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2003)
Bosentan therapy for pulmonary arterial hypertension
LJ Rubin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Plasmacytoid dendritic cells (natural interferon-α/β-producing cells) accumulate in cutaneous lupus erythematosus lesions
L Farkas et al.
AMERICAN JOURNAL OF PATHOLOGY (2001)
European multicentre study to define disease activity criteria for systemic sclerosis.: II.: Identification of disease activity variables and development of preliminary activity indexes
G Valentini et al.
ANNALS OF THE RHEUMATIC DISEASES (2001)
分享论文
